Lactoferrin protects against concanavalin A-induced liver injury in mice

Liver International

Volumn 30, Issue 4, 2010, Pages 623-632

  Yin, Hao ^a   Cheng, Linling ^a   Agarwal, Chapla ^a,b   Agarwal, Rajesh ^a,b   Ju, Cynthia ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

Concanavalin A; IFN ; IL 4; Lactoferrin; Liver

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 4; LACTOFERRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEPATITIS; LIVER PROTECTION; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CATTLE; CONCANAVALIN A; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; FLOW CYTOMETRY; HEPATITIS; IMMUNOHISTOCHEMISTRY; INTERFERONS; INTERLEUKIN-4; LACTOFERRIN; LIVER; MALE; MICE; MICE, INBRED C57BL; PROBABILITY; RANDOM ALLOCATION; TH1 CELLS;

EID: 77950625993     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02199.x     Document Type: Article

References (38)

1. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992, 90:196-203.
2. Takeda K, Hayakawa Y, Van Kaer L. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 2000, 97:5498-503.
3. Kusters S, Gantner F, Kunstle G, Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996, 111:462-71.
4. Watanabe Y, Morita M, Akaike T. Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology 1996, 24:702-10.
5. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995, 21:190-8.
6. Kaneko Y, Harada M, Kawano T. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 2000, 191:105-14.
7. Mizuhara H, Uno M, Seki N. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 1996, 23:1608-15.
8. Nicoletti F, Zaccone P, Xiang M. Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein. Cytokine 2000, 12:315-23.
9. Tagawa Y, Sekikawa K, Iwakura Y. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol 1997, 159:1418-28.
10. Toyabe S, Seki S, Iiai T. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J Immunol 1997, 159:1537-42.
11. Jaruga B, Hong F, Sun R, Radaeva S, Gao B. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J Immunol 2003, 171:3233-44.
12. Brock JH. The physiology of lactoferrin. Biochem Cell Biol 2002, 80:1-6.
13. Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica 1995, 80:252-67.
14. Masson PL, Heremans JF. Lactoferrin in milk from different species. Comp Biochem Physiol B 1971, 39:119-29.
15. Cumberbatch M, Dearman RJ, Uribe-Luna S. Regulation of epidermal Langerhans cell migration by lactoferrin. Immunology 2000, 100:21-8.
16. Togawa J, Nagase H, Tanaka K. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Am J Physiol Gastrointest Liver Physiol 2002, 283:G187-95.
17. Van Snick JL, Masson PL. The binding of human lactoferrin to mouse peritoneal cells. J Exp Med 1976, 144:1568-80.
18. Mazurier J, Legrand D, Hu WL, Montreuil J, Spik G. Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors by antiligand-affinity chromatography. Eur J Biochem 1989, 179:481-7.
19. Li KJ, Lu MC, Hsieh SC. Release of surface-expressed lactoferrin from polymorphonuclear neutrophils after contact with CD4+ T cells and its modulation on Th1/Th2 cytokine production. J Leukoc Biol 2006, 80:350-8.
20. Griffiths CE, Cumberbatch M, Tucker SC. Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans. Br J Dermatol 2001, 144:715-25.
21. Tsuda H, Sekine K, Fujita K, Ligo M. Cancer prevention by bovine lactoferrin and underlying mechanisms - a review of experimental and clinical studies. Biochem Cell Biol 2002, 80:131-6.
22. Kaito M, Iwasa M, Fujita N. Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin. J Gastroenterol Hepatol 2007, 22:1894-7.
23. Yin H, Cheng L, Langenbach R, Ju C. Prostaglandin I(2) and E(2) mediate the protective effects of cyclooxygenase-2 in a mouse model of immune-mediated liver injury. Hepatology 2007, 45:159-69.
24. Hatada S, Ohta T, Shiratsuchi Y, Hatano M, Kobayashi Y. A novel accessory role of neutrophils in concanavalin A-induced hepatitis. Cell Immunol 2005, 233:23-9.
25. Lee SH, Park SW, Pyo CW. Requirement of the JNK-associated Bcl-2 pathway for human lactoferrin-induced apoptosis in the Jurkat leukemia T cell line. Biochimie 2009, 91:102-8.
26. Bonder CS, Ajuebor MN, Zbytnuik LD, Kubes P, Swain MG. Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis. J Immunol 2004, 172:45-53.
27. Ajuebor MN, Hogaboam CM, Le T, Proudfoot AE, Swain MG. CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver. Eur J Immunol 2004, 34:2907-18.
28. Shimazaki K, Tanaka T, Kon H. Separation and characterization of the C-terminal half molecule of bovine lactoferrin. J Dairy Sci 1993, 76:946-55.
29. Ashorn RG, Eskola J, Tuohimaa PJ, Krohn KJ. Effect of the progesterone-inducible proteins human lactoferrin and chicken avidin on lymphocyte proliferation. Hum Reprod 1986, 1:149-51.
30. Cho JK, Azuma N, Lee CH, Yu JH, Kanno C. Purification of membrane-bound lactoferrin from the human milk fat globule membrane. Biosci Biotechnol Biochem 2000, 64:633-5.
31. Komine K, Kuroishi T, Ozawa A. Cleaved inflammatory lactoferrin peptides in parotid saliva of periodontitis patients. Mol Immunol 2007, 44:1498-508.
32. Kobayashi S, Sato R, Aoki T. Effect of bovine lactoferrin on functions of activated feline peripheral blood mononuclear cells during chronic feline immunodeficiency virus infection. J Vet Med Sci 2008, 70:429-35.
33. Miyauchi H, Kaino A, Shinoda I, Fukuwatari Y, Hayasawa H. Immunomodulatory effect of bovine lactoferrin pepsin hydrolysate on murine splenocytes and Peyer's patch cells. J Dairy Sci 1997, 80:2330-9.
34. Lohr HF, Schlaak JF, Gerken G. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994, 14:161-6.
35. Martinez OM, Villanueva JC, Gershwin ME, Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995, 21:113-9.
36. Prendiville J, Thatcher N, Lind M. Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer - a phase I toxicity study and pharmacokinetic analysis. Eur J Cancer 1993, 29A:1700-7.
37. Leach MW, Snyder EA, Sinha DP, Rosenblum IY. Safety evaluation of recombinant human interleukin-4. I. Preclinical studies. Clin Immunol Immunopathol 1997, 83:8-11.
38. Guillot C, Coathalem H, Chetritt J. Lethal hepatitis after gene transfer of IL-4 in the liver is independent of immune responses and dependent on apoptosis of hepatocytes: a rodent model of IL-4-induced hepatitis. J Immunol 2001, 166:5225-35.